Business & Industry

AstraZeneca has gone on to announce a newly expanded manufacturing facility located in Coppell, Texas, U.S., which is going to double production of Lokelma for the advantages of patients across the U.S. as well as around the world. This $445 million...

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression to phase 2 clinical trials in Malawi. Demonstrates Recipharm’s agility and flexibility, completing full tech transfer, scale-up and process optimisation within three months. Strengthens Recipharm’s position as a trusted partner...

Innovations in Injectable and Parenteral Drug Delivery Systems The evolution of injectable drug delivery systems marks a transformative period in pharmaceutical therapeutics, where technological sophistication converges with patient-centered design to revolutionize how medications reach their targets. Global market valuations exceeding...

Advances in Lipid-Based Drug Formulation for Solubility Enhancement The pharmaceutical industry faces a persistent challenge that threatens to derail promising drug candidates before they reach patients. Poor aqueous solubility afflicts over 70% of new molecular entities in development pipelines, creating...

Thermo Fisher Scientific Inc., the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through the use of artificial intelligence (AI) with OpenAI. This collaboration will help to improve the...

Enhancing Bioavailability Through Advanced Drug Delivery Platforms The pharmaceutical industry confronts an enduring challenge where promising therapeutic molecules fail clinical translation due to inadequate bioavailability. Advanced drug delivery bioavailability enhancement has emerged as a critical enabler transforming compounds with poor...

The pharmaceutical industry confronts a formidable obstacle that threatens to derail promising therapeutic candidates before they reach patients. Poor aqueous solubility afflicts over 70% of new chemical entities in development pipelines, creating fundamental challenges for drug absorption and bioavailability...